Differential oxidative modification of proteins in MRL+/+ and MRL/lpr mice: Increased formation of lipid peroxidation-derived aldehyde-protein adducts may contribute to accelerated onset of autoimmune response

References

• Anam K, Amare M, Naik S, Szabo KA, Davis TA. Severe tissue trauma triggers the autoimmune state systemic lupus erythematosus in the MRL/++ lupus-prone mouse. Lupus 2009;18:318–331.
   Google Scholar
• Danchenko N, Satia JA, Anthony MS. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus 2006;15:308–318.
   PubMed Web of Science ®Google Scholar
• Kurien BT, Hensley K, Bachmann M, Scofield RH. Oxidatively modified autoantigens in autoimmune diseases. Free Radic Biol Med 2006;41:549–556.
   PubMed Web of Science ®Google Scholar
• Kurien BT, Scofield RH. Autoimmunity and oxidatively modified autoantigens. Autoimmun Rev 2008;7:567–573.
   PubMed Web of Science ®Google Scholar
• Bagavant H, Fu SM. Pathogenesis of kidney disease in systemic lupus erythematosus. Curr Opin Rheumatol 2009;21: 489–494.
   PubMed Web of Science ®Google Scholar
• Wang G, Pierangeli SS, Papalardo E, Ansari GAS, Khan MF. Markers of oxidative and nitrosative stress in systemic lupus erythematosus: correlation with disease activity. Arthritis Rheum 2010;62:2064–2072.
   PubMed Web of Science ®Google Scholar
• Jacobson DL, Gange SJ, Rose NR, Graham NM. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 1997;84:223–243.
   PubMedGoogle Scholar
• Walsh SJ, Rau LM. Autoimmune diseases: a leading cause of death among young and middle-aged women in the United States. Am J Public Health 2000;90:1463–1466.
   PubMed Web of Science ®Google Scholar
• Theofilopoulos AN, Dixon FJ. Murine models of systemic lupus erythematosus. Adv Immunol 1985;37:269–390.
   PubMed Web of Science ®Google Scholar
• Field M, Brennan FM, McCarthy D, Mumford P, Maini RN. MRL-lpr/lpr mice show an impairment of IgG aggregate removal which relates to parameters of disease activity. Immunology 1987;61:463–467.
   Google Scholar
• Reilly CM, Gilkeson GS. Use of genetic knockouts to modulate disease expression in a murine model of lupus, MRL/lpr mice. Immunol Res 2002;25:143–153.
   PubMed Web of Science ®Google Scholar
• Bobé P, Bonardelle D, Benihoud K, Opolon P, Chelbi-Alix MK. Arsenic trioxide: A promising novel therapeutic agent for lymphoproliferative and autoimmune syndromes in MRL/lpr mice. Blood 2006;108:3967–3975.
   PubMed Web of Science ®Google Scholar
• Sadanaga A, Nakashima H, Akahoshi M, Masutani K, Miyake K, Igawa T, . Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice. Arthritis Rheum 2007;56: 1618–1628.
   PubMedGoogle Scholar
• Izui S, Kelley VE, Masuda K, Yoshida H, Roths JB, Murphy ED. Induction of various autoantibodies by mutant gene lpr in several strains of mice. J Immunol 1985;133: 227–233.
   Google Scholar
• Khan MF, Kaphalia BS, Prabhakar BS, Kanz M, Ansari GAS. Trichloroethene-induced autoimmune response in female MRL +/+ mice. Toxicol Appl Pharmacol 1995;134: 155–160.
   PubMed Web of Science ®Google Scholar
• Khan MF, Wu X, Ansari GAS. Anti-malondialdehyde antibodies in MRL+/+ mice treated with trichloroethene and dichloroacetyl chloride: possible role of lipid peroxidation in autoimmunity. Toxicol Appl Pharmacol 2001;170:88–92.
   PubMed Web of Science ®Google Scholar
• Hadjigogos K. The role of free radicals in the pathogenesis of rheumatoid arthritis. Panminerva Med 2003;45:7–13.
   PubMed Web of Science ®Google Scholar
• Kurien BT, Scofield RH. Free radical mediated peroxidative damage in systemic lupus erythematosus. Life Sci 2003;73: 1655–1666.
   PubMed Web of Science ®Google Scholar
• Frostegard J, Svenungsson E, Wu R, Gunnarsson I, Lundberg IE, Klareskog L, . Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations. Arthritis Rheum 2005;52:192–200.
   PubMed Web of Science ®Google Scholar
• Wang G, König R, Ansari GAS, Khan MF. Lipid peroxidation-derived aldehyde-protein adducts contribute to trichloroethene-mediated autoimmunity via activation of CD4+ T cells. Free Radic Biol Med 2008;44:1475–1482.
   PubMed Web of Science ®Google Scholar
• Morgan PE, Sturgess AD, Davies MJ. Evidence for chronically elevated serum protein oxidation in systemic lupus erythematosus patients. Free Radic Res 2009;43:117–127.
   PubMed Web of Science ®Google Scholar
• Shah D, Kiran R, Wanchu A, Bhatnagar A. Oxidative stress in systemic lupus erythematosus: relationship to Th1 cytokine and disease activity. Immunol Lett 2010;129:7–12.
   PubMed Web of Science ®Google Scholar
• Shah D, Wanchu A, Bhatnagar A. Interaction between oxidative stress and chemokines: possible pathogenic role in systemic lupus erythematosus and rheumatoid arthritis. Immunobiology 2011;216:1010–1017.
   PubMed Web of Science ®Google Scholar
• Grune T, Michel P, Sitte N, Eggert W, Albrecht-Nebe H, Esterbauer H, . Increased levels of 4-hydroxynonenal modified proteins in plasma of children with autoimmune diseases. Free Radic Biol Med 1997;23:357–360.
   PubMed Web of Science ®Google Scholar
• Ben Mansour R, Lassoued S, Elgaied A, Haddouk S, Marzouk S, Bahloul Z, . Enhanced reactivity to malondialdehyde-modified proteins by systemic lupus erythematosus autoantibodies. Scand J Rheumatol 2010;39:247–253.
   PubMed Web of Science ®Google Scholar
• Kurien BT, Porter A, Dorri Y, Iqbal S, D‘Souza A, Singh A, . Degree of modification of Ro60 by the lipid peroxidation by-product 4-hydroxy-2-nonenal may differentially induce Sjögren syndrome or systemic lupus erythematosus in BALB/c mice. Free Radic Biol Med 2011;50:1222–1233.
   PubMed Web of Science ®Google Scholar
• Khan MF, Wu X, Kaphalia BS, Boor PJ, Ansari GAS. Acute hematopoietic toxicity of aniline in rats. Toxicol Lett 1997;92: 31–37.
   PubMed Web of Science ®Google Scholar
• Khan MF, Wu X, Boor PJ, Ansari GAS. Oxidative modification of lipids and proteins in aniline-induced splenic toxicity. Toxicol Sci 1999;48:134–140.
   PubMed Web of Science ®Google Scholar
• Wang J, Hu B, Meng Y, Zhang C, Li K, Hui C. The level of malondialdehyde-modified LDL and LDL immune complexes in patients with rheumatoid arthritis. Clin Biochem 2009;42: 1352–1357.
   Google Scholar
• Reed TT, Pierce WM, Markesbery WR, Butterfield DA. Proteomic identification of HNE-bound proteins in early Alzheimer disease: Insights into the role of lipid peroxidation in the progression of AD. Brain Res 2009;1274:66–76.
   PubMed Web of Science ®Google Scholar
• D‘souza A, Kurien BT, Rodgers R, Shenoi J, Kurono S, Matsumoto H, . Detection of catalase as a major protein target of the lipid peroxidation product 4-HNE and the lack of its genetic association as a risk factor in SLE. BMC Med Genet 2008;9:62–69.
   PubMedGoogle Scholar
• Wang G, Cai P, Ansari GA, Khan MF. Oxidative and nitrosative stress in trichloroethene-mediated autoimmune response. Toxicology 2007;229:186–193.
   PubMed Web of Science ®Google Scholar
• Wang G, Ansari GA, Khan MF. Involvement of lipid peroxidation-derived aldehyde-protein adducts in autoimmunity mediated by trichloroethene. J Toxicol Environ Health, Part A 2007;70:1977–1985.
   PubMed Web of Science ®Google Scholar
• Egner W. The use of laboratory tests in the diagnosis of SLE. J Clin Pathol 2000;53:424–432.
   PubMed Web of Science ®Google Scholar
• Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, . Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003;349:1526–1533.
   PubMed Web of Science ®Google Scholar
• Reveille JD. Predictive value of autoantibodies for activity of systemic lupus erythematosus. Lupus 2004;13:290–297.
   PubMed Web of Science ®Google Scholar
• Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991;11:81–128.
   PubMed Web of Science ®Google Scholar
• Uchida K, Szweda LI, Chae HZ, Stadtman ER. Immunochemical detection of 4-hydroxynonenal protein adducts in oxidized hepatocytes. Proc Natl Acad Sci USA 1993;90:8742–8746.
   PubMed Web of Science ®Google Scholar
• Tuma DJ. Role of malondialdehyde-acetaldehyde adducts in liver injury. Free Radic Biol Med 2002;32:303–308.
   PubMed Web of Science ®Google Scholar
• Toyoda K, Nagae R, Akagawa M, Ishino K, Shibata T, Ito S, . Protein-bound 4-hydroxy-2-nonenal: an endogenous triggering antigen of anti-DNA response. J Biol Chem 2007;282: 25769–25778.
   PubMed Web of Science ®Google Scholar
• Grimsrud PA, Xie H, Griffin TJ, Bernlohr DA. Oxidative stress and covalent modification of protein with bioactive aldehydes. J Biol Chem 2008;283:21837–21841.
   PubMed Web of Science ®Google Scholar
• Wuttge DM, Bruzelius M, Stemme S. T-cell recognition of lipid peroxidation products breaks tolerance to self-proteins. Immunology 1999;98:273–279.
   PubMed Web of Science ®Google Scholar
• Scofield RH, Kurien BT, Ganick S, McClain MT, Pye Q, James JA, . Modification of lupus-associated 60-kDa Ro protein with the lipid oxidation product 4-hydroxy-2-nonenal increases antigenicity and facilitates epitope spreading. Free Radic Biol Med 2005;38:719–728.
   PubMed Web of Science ®Google Scholar
• Uchida K. Future of toxicology-lipid peroxidation in the future: from biomarker to etiology. Chem Res Toxicol 2007; 20:3–5.
   PubMed Web of Science ®Google Scholar
• Spatz L, Iliev A, Saenko V, Jones L, Irigoyen M, Manheimer-Lory A, . Studies on the structure, regulation, and pathogenic potential of anti-dsDNA antibodies. Methods 1997;11:70–78.
   Google Scholar
• Tung KS, DeHoratius RJ, Williams RC. Study of circulating immune complex size in systemic lupus erythematosus. Clin Exp Immunol 1981;43:615–625.
   Google Scholar
• Wang G, Wang J, Fan X, Ansari GA, Khan MF. Protein adducts of malondialdehyde and 4-hydroxynonenal contribute to trichloroethene-mediated autoimmunity via activating Th17 cells: dose- and time-response studies in female MRL+/+ mice. Toxicology 2012;292:113–122.
   PubMed Web of Science ®Google Scholar
• Mangini AJ, Lafyatis R, Van Seventer JM. Type I interferons inhibition of inflammatory T helper cell responses in systemic lupus erythematosus. Ann N Y Acad Sci 2007;1108:11–23.
   PubMed Web of Science ®Google Scholar
• Hickman-Brecks CL, Racz JL, Meyer DM, LaBranche TP, Allen PM. Th17 cells can provide B cell help in autoantibody induced arthritis. J Autoimmun 2011;36:65–75.
   PubMed Web of Science ®Google Scholar